Global Prostate Specific Antigen Sales Market Report 2018

Published On: Dec 2018

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 210655

This report studies the global Prostate Specific Antigen market status and forecast, categorizes the global Prostate Specific Antigen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Prostate Specific Antigen market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
...

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others

The study objectives of this report are:
To analyze and study the global Prostate Specific Antigen sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Prostate Specific Antigen players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prostate Specific Antigen are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Prostate Specific Antigen Manufacturers
Prostate Specific Antigen Distributors/Traders/Wholesalers
Prostate Specific Antigen Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Prostate Specific Antigen market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Prostate Specific Antigen Sales Market Report 2018
1 Prostate Specific Antigen Market Overview
1.1 Product Overview and Scope of Prostate Specific Antigen
1.2 Classification of Prostate Specific Antigen by Product Category
1.2.1 Global Prostate Specific Antigen Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Prostate Specific Antigen Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 G-115
1.2.4 INO-5150
1.2.5 ADXS-PSA
1.2.6 AEZS-120
1.2.7 Others
1.3 Global Prostate Specific Antigen Market by Application/End Users
1.3.1 Global Prostate Specific Antigen Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Prostate Cancer
1.3.3 Metastatic Hormone Refractory Prostate Cancer
1.3.4 Others
1.4 Global Prostate Specific Antigen Market by Region
1.4.1 Global Prostate Specific Antigen Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Prostate Specific Antigen Status and Prospect (2013-2025)
1.4.3 Europe Prostate Specific Antigen Status and Prospect (2013-2025)
1.4.4 China Prostate Specific Antigen Status and Prospect (2013-2025)
1.4.5 Japan Prostate Specific Antigen Status and Prospect (2013-2025)
1.4.6 Southeast Asia Prostate Specific Antigen Status and Prospect (2013-2025)
1.4.7 India Prostate Specific Antigen Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Prostate Specific Antigen (2013-2025)
1.5.1 Global Prostate Specific Antigen Sales and Growth Rate (2013-2025)
1.5.2 Global Prostate Specific Antigen Revenue and Growth Rate (2013-2025)

2 Global Prostate Specific Antigen Competition by Players/Suppliers, Type and Application
2.1 Global Prostate Specific Antigen Market Competition by Players/Suppliers
2.1.1 Global Prostate Specific Antigen Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Prostate Specific Antigen Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Prostate Specific Antigen (Volume and Value) by Type
2.2.1 Global Prostate Specific Antigen Sales and Market Share by Type (2013-2018)
2.2.2 Global Prostate Specific Antigen Revenue and Market Share by Type (2013-2018)
2.3 Global Prostate Specific Antigen (Volume and Value) by Region
2.3.1 Global Prostate Specific Antigen Sales and Market Share by Region (2013-2018)
2.3.2 Global Prostate Specific Antigen Revenue and Market Share by Region (2013-2018)
2.4 Global Prostate Specific Antigen (Volume) by Application

3 United States Prostate Specific Antigen (Volume, Value and Sales Price)
3.1 United States Prostate Specific Antigen Sales and Value (2013-2018)
3.1.1 United States Prostate Specific Antigen Sales and Growth Rate (2013-2018)
3.1.2 United States Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
3.1.3 United States Prostate Specific Antigen Sales Price Trend (2013-2018)
3.2 United States Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
3.3 United States Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
3.4 United States Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

4 Europe Prostate Specific Antigen (Volume, Value and Sales Price)
4.1 Europe Prostate Specific Antigen Sales and Value (2013-2018)
4.1.1 Europe Prostate Specific Antigen Sales and Growth Rate (2013-2018)
4.1.2 Europe Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
4.1.3 Europe Prostate Specific Antigen Sales Price Trend (2013-2018)
4.2 Europe Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

5 China Prostate Specific Antigen (Volume, Value and Sales Price)
5.1 China Prostate Specific Antigen Sales and Value (2013-2018)
5.1.1 China Prostate Specific Antigen Sales and Growth Rate (2013-2018)
5.1.2 China Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
5.1.3 China Prostate Specific Antigen Sales Price Trend (2013-2018)
5.2 China Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
5.3 China Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
5.4 China Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

6 Japan Prostate Specific Antigen (Volume, Value and Sales Price)
6.1 Japan Prostate Specific Antigen Sales and Value (2013-2018)
6.1.1 Japan Prostate Specific Antigen Sales and Growth Rate (2013-2018)
6.1.2 Japan Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
6.1.3 Japan Prostate Specific Antigen Sales Price Trend (2013-2018)
6.2 Japan Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Prostate Specific Antigen (Volume, Value and Sales Price)
7.1 Southeast Asia Prostate Specific Antigen Sales and Value (2013-2018)
7.1.1 Southeast Asia Prostate Specific Antigen Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Prostate Specific Antigen Sales Price Trend (2013-2018)
7.2 Southeast Asia Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

8 India Prostate Specific Antigen (Volume, Value and Sales Price)
8.1 India Prostate Specific Antigen Sales and Value (2013-2018)
8.1.1 India Prostate Specific Antigen Sales and Growth Rate (2013-2018)
8.1.2 India Prostate Specific Antigen Revenue and Growth Rate (2013-2018)
8.1.3 India Prostate Specific Antigen Sales Price Trend (2013-2018)
8.2 India Prostate Specific Antigen Sales Volume and Market Share by Players (2013-2018)
8.3 India Prostate Specific Antigen Sales Volume and Market Share by Type (2013-2018)
8.4 India Prostate Specific Antigen Sales Volume and Market Share by Application (2013-2018)

9 Global Prostate Specific Antigen Players/Suppliers Profiles and Sales Data
9.1 Advaxis, Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Prostate Specific Antigen Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Aeterna Zentaris Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Prostate Specific Antigen Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bavarian Nordic A/S
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Prostate Specific Antigen Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Curevac AG
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Prostate Specific Antigen Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 GenSpera, Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Prostate Specific Antigen Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Inovio Pharmaceuticals, Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Prostate Specific Antigen Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 OncBioMune Pharmaceuticals Inc.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Prostate Specific Antigen Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
...

10 Prostate Specific Antigen Maufacturing Cost Analysis
10.1 Prostate Specific Antigen Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Prostate Specific Antigen
10.3 Manufacturing Process Analysis of Prostate Specific Antigen

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Prostate Specific Antigen Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Prostate Specific Antigen Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Prostate Specific Antigen Market Forecast (2018-2025)
14.1 Global Prostate Specific Antigen Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Prostate Specific Antigen Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Prostate Specific Antigen Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Prostate Specific Antigen Price and Trend Forecast (2018-2025)
14.2 Global Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Prostate Specific Antigen Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Prostate Specific Antigen Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Prostate Specific Antigen Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Prostate Specific Antigen Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Prostate Specific Antigen Sales Forecast by Type (2018-2025)
14.3.2 Global Prostate Specific Antigen Revenue Forecast by Type (2018-2025)
14.3.3 Global Prostate Specific Antigen Price Forecast by Type (2018-2025)
14.4 Global Prostate Specific Antigen Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer